Third consecutive profitable quarter with continued strong growth
26 oct. 2015 08h52 HE
|
Exiqon A/S
Copenhagen, 2015-10-26 13:52 CET (GLOBE NEWSWIRE) --
Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”) today announced results for the third quarter and first nine months of...
Major shareholder announcement
08 oct. 2015 09h13 HE
|
Exiqon A/S
Copenhagen, 2015-10-08 15:13 CEST (GLOBE NEWSWIRE) --
Exiqon A/S, listed on NASDAQ Copenhagen (“EXQ”), has been informed by Teknoinvest VIII KS with its registered office at Smalgangen 3, 0188 Oslo,...
Storaktionærmeddelelse
08 oct. 2015 09h13 HE
|
Exiqon A/S
Copenhagen, 2015-10-08 15:13 CEST (GLOBE NEWSWIRE) --
Exiqon A/S, der er noteret på NASDAQ Copenhagen (“EXQ”), meddeler, at Teknoinvest VIII KS med adresse på Smalgangen 3, 0188 Oslo, Norge...
Exiqon erhverver alle rettighederne til nye biomarkører for prostatakræft fra Århus Universitetshospital.
02 sept. 2015 08h10 HE
|
Exiqon A/S
Copenhagen, 2015-09-02 14:10 CEST (GLOBE NEWSWIRE) --
Exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") annoncerede i dag, at selskabet har udtaget eksklusiv licens til to sæt validerede biomarkør profiler...
Exiqon acquires all rights to new prostate cancer biomarkers from Aarhus University Hospital.
02 sept. 2015 08h10 HE
|
Exiqon A/S
Copenhagen, 2015-09-02 14:10 CEST (GLOBE NEWSWIRE) --
Exiqon A/S (NASDAQ Copenhagen: “EXQ”) today announced that the company has exclusively licensed two sets of validated prostate cancer biomarkers...
Exiqon sætter analyse af menneskers genom på dagsordenen
26 août 2015 01h58 HE
|
Exiqon A/S
Copenhagen, 2015-08-26 07:58 CEST (GLOBE NEWSWIRE) --
Den teknologiske udvikling inden for genetisk analyse er løbet forud for den offentlige debat af, hvad vi kan og vil bruge de nye teknologiske...
Continued strong performance in the second quarter with 24% growth and profitability
25 août 2015 10h04 HE
|
Exiqon A/S
Copenhagen, 2015-08-25 16:04 CEST (GLOBE NEWSWIRE) --
Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”) today announced results for the second quarter and first six months of...
Exiqon launches ExiLERATE LNA™ qPCR product portfolio for analysis of mRNA and lncRNA
30 juin 2015 03h16 HE
|
Exiqon A/S
Copenhagen, 2015-06-30 09:16 CEST (GLOBE NEWSWIRE) --
Exiqon A/S (NASDAQ OMX: EXQ), a leading provider of flexible solutions for RNA analysis, today announced the launch of the ExiLERATE LNA™ qPCR...
Exiqon integrates RNAseq workflow in unique cloud-computing environment, XploreRNA™
30 juin 2015 02h54 HE
|
Exiqon A/S
Copenhagen, 2015-06-30 08:54 CEST (GLOBE NEWSWIRE) --
Exiqon A/S (NASDAQ OMX: EXQ), a leading provider of flexible solutions for RNA analysis, today announced the launch of its innovative XploreRNA™...
Exiqon integrerer RNA-sekvenserings work-flow i enestående cloud-løsning: XploreRNA™
30 juin 2015 02h54 HE
|
Exiqon A/S
Copenhagen, 2015-06-30 08:54 CEST (GLOBE NEWSWIRE) --
Exiqon A/S (NASDAQ OMX: EXQ), der er en førende leverandør af fleksible løsninger til RNA analyse, annoncerede i dag lanceringen af selskabets...